Industry
Epidyolex gains approval for seizures associated with tuberous sclerosis complex
TSC can cause epilepsy in up to 85 percent of those with the condition and up to 60 percent do not respond to standard anti-seizure medicines.
Fatima Rokib
Latest by Fatima Rokib
Industry
Cumbria’s first CBD cafe opens its doors
West Lakes Hemp aims to educate the public about CBD
Health
Cystic fibrosis and cannabis – new survey highlights lack of education
Almost three quarters of healthcare providers felt unprepared to answer patient’s questions about cannabis